The United States has the most number of coronavirus cases in the world. But rather than viewing the more than 1.5 million confirmed cases negatively, President Donald Trump says that it is just a reflection of his administration's successful testing.
“I view it as a badge of honor, really, it’s a badge of honor,” Donald Trump told reporters on Tuesday, according to Bloomberg. “It’s a great tribute to the testing and all of the work that a lot of professionals have done.”
Based on data from the Worldometers site, there are more than 1.5 million confirmed COVID-19 infections in the U.S. The country also has the highest number of fatalities with over 93 thousand deaths due to the pathogen.
The U.S. also posted the highest number of COVID-19 tests done with almost 13 million Americans already tested for the virus. The country with the second-highest number of tests is Russia with over 7.5 million tests done on its citizens.
Trump explained that it is only natural for the U.S. to have the highest number of confirmed coronavirus infections since it did the most number of tests. “If you’re testing 14 million people, you’re going to find many more cases,” the POTUS said.
He also added that viewed in this light, it’s not necessarily a bad thing to have the most number of cases. “Many of these people aren’t very sick but they still go down as a case, so, actually, the number of cases -- and we’re also a much bigger country than most,” Trump added. “So when we have a lot of cases, I don’t look at that as a bad thing, I look at that as, in a certain respect, as being a good thing because it means our testing is much better.”
But according to Bloomberg, the level of coronavirus testing done in the U.S. is not extraordinary. The nation is still behind Italy, Germany, and the U.K. in terms of the number of tests per 1,000 people. The publication also noted that the country is still facing testing shortages due to delays in the development and manufacturing of testing kits.


Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Japan Signals Potential Shift on Arms Exports, Opening Door to Ukraine Support
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
U.S. Fast-Tracks $8.6 Billion Arms Sales to Middle East Allies Amid Rising Tensions
EU Warns of Response as U.S. Considers 25% Tariffs on Car Imports
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Rising Tensions in US-Europe Relations Amid Trump Policies and Iran War
Poland Sees No Delays in U.S. Patriot Missile Defense Deliveries Despite Stockpile Concerns
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Trump Announces “Project Freedom” to Aid Stranded Ships in Strait of Hormuz
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
Trump Expands Cuba Sanctions Targeting Key Sectors and Foreign Entities
Oil Prices Hold Above $100 Amid Strait of Hormuz Tensions and U.S.-Iran Uncertainty 



